Loading clinical trials...
Loading clinical trials...
A Multi-center, Prospective, Non-intervention, Observational Study to Evaluate the Effectiveness and Safety of Switching to Pevarozet Tablet in Patients With Hypercholesterolemia Previously Treated With Atorvastatin or Rosuvastatin Monotherapy
Conditions
Locations
1
South Korea
Yongin Severance Hospital
Yongin-si, South Korea
Start Date
July 29, 2025
Primary Completion Date
July 1, 2028
Completion Date
January 1, 2029
Last Updated
August 7, 2025
NCT07473960
NCT06568601
NCT00353782
NCT07489209
NCT07037771
NCT07058077
Lead Sponsor
Ahn-Gook Pharmaceuticals Co.,Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions